Novavax, Inc.

NASDAQ: NVAX
$155.87
+$12.77 (+8.9%)
Closing price August 3, 2020
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Tuesday's top analyst upgrades, downgrades and initiations included Amazon.com, Apple, Bank of America, Cinemark, Coupa Software, Ecolab, Novavax, Pepsico, Procter & Gamble, Square and Walmart.
Markets looked like they would be crushed yet again on Monday. 24/7 Wall St. has tracked some stocks that either are defensive in general or were defying Monday’s big drop.
24/7 Wall St. has tracked some stocks that either are defensive in general or are defying Thursday’s big drop because they have some aspect of their business that might be immune to daily scares or...
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected coronavirus stocks increased.
More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at some of the biggest movers on the day tied to COVID-19.
24/7 Wall St. has tracked some stocks that either are defensive in general or are defying Monday's big drop because they have some aspect of their business that might be immune to daily scares or...
These stocks that are either defensive in general or are defying the big drop because they have some aspect of their business that might be immune to daily scares or because they are potential...
Friday's top analyst upgrades, downgrades and initiations included Beyond Meat, CBOE, Chesapeake Energy, Dollar General, FLIR Systems, Gilead Sciences, Lyft, Novavax, RBS, Uber and Zoom Video...
Novavax shares made a big step forward on Wednesday after the firm provided an update on its treatment for COVID-19.
Day two of the coronavirus scare is now in the books and practically all major American averages are down over 3% for their second consecutive day. Currently all the gains for the year for each of...
The broad markets are getting crushed on Monday on renewed fears of the spread of the coronavirus (Covid-19). But a handful of stocks were acting as a natural hedge to the virus news.
Here are the biotech companies with exposure to experimental vaccines whose shares saw the biggest boost from this past week's coronavirus news.
Here are some biotech companies with exposure to experimental vaccines whose shares are seeing the biggest boost from the latest coronavirus news.
As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares rise sharply.